RHÃN-KLINIKUM AG 17.08.2012 14:45 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification according to section 26 para. 1 WpHG UBS AG, Zürich, Switzerland, notified us pursuant to section 25 WpHG and pursuant to section 25a WpHG of the following: (1) UBS AG notified us pursuant to section 25 WpHG of the following: On 10 August 2012, UBS AG fell below the threshold of 5% of the voting rights of RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, UBS AG held 4.90% of the voting rights in RHÃN-KLINIKUM AG (equals 6,775,230 voting rights). From these voting rights a proportion of 2.91% (equals 4,015,830 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 2.00% (equals 2,759,400 voting rights) is based on (financial/other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.00% (equals 0 voting rights) is held indirectly. The exercise period of the instruments pursuant to section 25 WpHG is at any time. (2) UBS AG notified us pursuant to section 25a WpHG of the following: On 10 August 2012, UBS AG fell below the threshold of 5% of the voting rights of RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, UBS AG held 4.91% of the voting rights in RHÃN-KLINIKUM AG (equals 6,792,385 voting rights). On that date, the composition of the voting rights held by UBS AG was as follows: A proportion of 2.91% (equals 4,015,830 voting rights) was based on voting rights pursuant to sections 21, 22 WpHG. A proportion of 2.00% (equals 2,759,400 voting rights) was based on (financial/other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.00% (equals 0 voting rights) is held indirectly. A proportion of 0.01% (equals 17,155 voting rights) was based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 0.00% (equals 0 voting rights) is held indirectly. The (financial/other) instruments pursuant to section 25a WpHG are described as Equity Swaps with expiration date 4 February 2015. Bad Neustadt a.d. Saale, 17 August 2012 The Board of Management ___________________________________________________________________________ Dr. Kai G. Klinger Head of Investor Relations RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 17.08.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: RHÃN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG